Quantitative Interpretation of Age-Specific Mortality Reductions From the Swedish Breast Cancer-Screening Trials von Koning, Harry J.de, Boer, Rob, Warmerdam, Peter G., Beemsterboer, Petra M. M., van, Paul J.der Maas

Volltext

Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness von van Ballegooijen, M, van den Akker-van Marle, ME, Warmerdam, PG, Meijer, CJLM, Walboomers, JMM, Habbema, JDF

Volltext

Radiation risk of mammography related to benefit in screening programmes: a favourable balance? von Beemsterboer, P M, Warmerdam, P G, Boer, R, de Koning, H J

Volltext

Prediction of the effects and costs of breast‐cancer screening in Germany von Beemsterboer, Petra M. M., De Koning, Harry J., Warmerdam, Peter G., Boer, Rob, Swart, Enno, Dierks, Marie‐Luise, Robra, Bernt‐Peter

Volltext

Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany von Warmerdam, P G, de Koning, H J, Boer, R, Beemsterboer, P M, Dierks, M L, Swart, E, Robra, B P

Volltext

Screening for breast cancer in Catalonia. Which policy is to be preferred? von Beemsterboer, Petra M M, Warmerdam, Peter G, Boer, Rob, Borras, Joseph M, Moreno, Victor, Viladiu, Pau, De Koning, Harry J

Volltext

Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases von Huijts, Petra E A, Vreeswijk, Maaike P G, Kroeze-Jansema, Karin H G, Jacobi, Catharina E, Seynaeve, Caroline, Krol-Warmerdam, Elly M M, Wijers-Koster, Pauline M, Blom, Jannet C, Pooley, Karen A, Klijn, Jan G M, Tollenaar, Rob A E M, Devilee, Peter, van Asperen, Christi J

Volltext